GAMBARAN PENGGUNAAN OBAT PADA PASIEN PENYAKIT GINJAL KRONIK (PGK) YANG MENJALANI HEMODIALISIS DI RS X BEKASI PERIODE JANUARI – MARET 2020

Niko Prasetya; Herty Nur Tanty; Honey Iskandar; Retnayu Pranacistri

doi:10.33759/jrki.v4i2.269

Niko Prasetya Sekolah Tinggi Ilmu Kesehatan IKIFA
Herty Nur Tanty Sekolah Tinggi Ilmu Kesehatan IKIFA
Honey Iskandar Sekolah Tinggi Ilmu Kesehatan IKIFA
Retnayu Pranacistri Sekolah Tinggi Ilmu Kesehatan IKIFA

DOI: https://doi.org/10.33759/jrki.v4i2.269

Keywords: Penyakit Ginjal Kronik (PGK), Hemodialisis, Obat Ginjal Kronik, Rumah Sakit X Bekasi

Abstract

Chronic Kidney Disease (CKD) is a condition of kidney damage that occurs for 3 months or more in the form of structural or functional abnormalities of the kidneys with or without a decrease in the Glomerular Filtration Rate. So far, treatment for CKD can be done by hemodialysis, Continuous Ambulatory Peritoneal Dialysis (CAPD) and kidney transplantation. This study aims to determine the description of the use of drugs in CKD patients undergoing hemodialysis at Hospital X Bekasi from January to March 2020. This study was conducted using a descriptive method. Sampling in January - March 2020 was carried out with the total sampling method, namely all electronic prescription sheets of CKD patients undergoing hemodialysis at Hospital X Bekasi. Data were collected by calculating the amount and percentage based on the active substance and class of drugs used by CKD patients undergoing hemodialysis. Based on the results of observations of electronic prescriptions of drugs used by CKD patients undergoing hemodialysis at Hospital X Bekasi during January - March 2020, it can be concluded that the use of drugs based on the active substance is Calcium carbonate 500 mg capsules as many as 10580 capsules (59.07%), Sodium bicarbonate 500 mg tablets 1725 tablets (9.63%), Gentamicin sulfate 80 mg/2 ml inj 868 ampoules (4.85%), Vitamin C (ascorbic acid) 200 mg/2 ml inj 753 ampoules (4.21% ), Recombinant human erythropoietin 3000 IU 678 injection (3.78%).

Downloads

Download data is not yet available.

References

(IHME), H. M. and E. (2017). Global Burden of Disease Study 2017. The Lancet, 5, 1–27.

Cindy Monica, S.Farm, A. (2017). Drug Related Problem pada Pasien PGK stadium 5 yang menjalani Heomdialisa di Instalasi Hemodialisa RSUP Dr.M.Djamil Padang. 1–14.

Gagal, P., Di, G., Prof, R., & Manado, R. D. K. (2017). Evaluasi Kerasionalan Penggunaan Antibiotik Pada Pasien Gagal Ginjal Di Rsup Prof. Dr. R. D. Kandou Manado. Pharmacon, 6(3), 10–19.

IRR. (2018). 11th Report Of Indonesian Renal Registry 2018. In Irr.

Kade Dwi Yasinta Hermayanti. (2018). Gambaran Asupan Kalsium Dan Fosfor Pada Penderita Gagal Ginjal Kronik Rawat Jalan Yang Menjalani Hemodialisa Dan Non Hemodialisa Di Rsud Badung Mangusada (Vol. 1, Issue 1). https://doi.org/10.29333/aje.2019.423a

Kemenkes RI 2016. (2016). Peraturan Menteri Kesehatan Ri No 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian Di RS.

Kemenkes RI 2017. (n.d.). Infodatin Pusat Data dan Informasi Kementerian Kesehatan RI tentang Situasi Penyakit Ginjal Kronis.

Kemenkes RI 2018. (2018). Hasil Utama Riset Kesehatan Dasar (RISKESDAS). 44(8), 1–200.

Mahdiana, R. (2011). Paduan Kesehatan Jantung & Ginjal. In Paduan Kesehatan Jantung & Ginjal (Vol. 5, Issue 4, pp. 19–30). Citra Medical.

MIMS Indonesia- Calcium Carbonate. (2020). In MIMS - Drug Information,Disease,News .

Rekam Medis Rumah Sakit X Bekasi. (2020). Data Pasien Hemodialisa tahun 2020.